HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Hsui Tsai Selected Research

Mouth Neoplasms (Oral Cancer)

7/2020Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells.
1/2020Monocyte Chemoattractant Protein 1 Promotes VEGF-A Expression in OSCC by Activating ILK and MEK1/2 Signaling and Downregulating miR-29c.
1/2019ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients.
1/2018Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
9/2017The differential regulation of microRNAs is associated with oral cancer.
6/2017Combined Genetic Biomarkers and Betel Quid Chewing for Identifying High-Risk Group for Oral Cancer Occurrence.
5/2017Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics.
1/2017Portable LED-induced autofluorescence spectroscopy for oral cancer diagnosis.
1/2017Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma.
7/2016AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Hsui Tsai Research Topics

Disease

49Neoplasms (Cancer)
04/2021 - 01/2002
45Mouth Neoplasms (Oral Cancer)
07/2020 - 01/2004
23Squamous Cell Carcinoma of Head and Neck
04/2021 - 02/2007
14Carcinogenesis
04/2021 - 02/2007
14Nasopharyngeal Carcinoma
01/2020 - 01/2002
6Neoplasm Metastasis (Metastasis)
01/2020 - 09/2010
5Hypopharyngeal Neoplasms
02/2021 - 11/2007
5Genomic Instability
06/2014 - 09/2008
4Lymphatic Metastasis
11/2019 - 03/2016
4Carcinoma (Carcinomatosis)
10/2018 - 11/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2018 - 11/2002
4Infections
12/2015 - 06/2007
4Hyperplasia
12/2015 - 06/2003
3Inflammation (Inflammations)
04/2021 - 01/2002
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 06/2003
3Hearing Loss (Hearing Impairment)
03/2020 - 07/2011
2Paralysis (Palsy)
10/2021 - 01/2016
2Hemorrhage
07/2021 - 01/2008
2Diabetes Mellitus
02/2021 - 04/2013
2Hypoxia (Hypoxemia)
01/2019 - 07/2011
2Tongue Neoplasms (Tongue Neoplasm)
10/2018 - 01/2010
2Bacterial Infections (Bacterial Infection)
01/2015 - 02/2014
2Rhinosinusitis
02/2014 - 03/2006
2Nasal Polyps (Nasal Polyp)
04/2013 - 03/2006
2Ototoxicity
07/2011 - 01/2008
2Ischemia
07/2011 - 02/2011
1Papillomavirus Infections
03/2022
1Extranodal Extension
02/2022
1Globus Sensation
07/2021
1Sleepiness
07/2021
1Apnea
07/2021
1Pain (Aches)
07/2021
1Dysgeusia (Parageusia)
07/2021
1Deglutition Disorders (Dysphagia)
07/2021
1Type 2 Diabetes Mellitus (MODY)
02/2021
1COVID-19
10/2020

Drug/Important Bio-Agent (IBA)

20Biomarkers (Surrogate Marker)IBA
03/2022 - 05/2005
12Proteins (Proteins, Gene)FDA Link
11/2019 - 03/2006
8DNA (Deoxyribonucleic Acid)IBA
06/2014 - 09/2008
7Codon (Codons)IBA
09/2012 - 01/2002
6Pharmaceutical PreparationsIBA
02/2021 - 09/2010
5Arecoline (Arecolin)IBA
04/2021 - 01/2010
5Messenger RNA (mRNA)IBA
01/2019 - 07/2003
5CytokinesIBA
07/2014 - 01/2002
3LigandsIBA
01/2018 - 04/2011
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2017 - 04/2011
3Fenofibrate (CiL)FDA LinkGeneric
07/2016 - 04/2011
3indole-3-carbinolIBA
02/2012 - 08/2007
3Protein Isoforms (Isoforms)IBA
08/2011 - 03/2006
3Genetic Markers (Genetic Marker)IBA
05/2005 - 01/2002
2arecoline 1-oxideIBA
04/2021 - 06/2015
2Celecoxib (Celebrex)FDA Link
07/2020 - 01/2017
2AlbuminsIBA
03/2020 - 11/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 05/2005
2MicroRNAs (MicroRNA)IBA
01/2019 - 09/2017
2Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2019 - 11/2013
2CC ChemokinesIBA
01/2018 - 05/2017
2LipidsIBA
07/2016 - 04/2011
2PPAR alphaIBA
07/2016 - 04/2011
2Dihydrotachysterol (AT 10)IBA
01/2016 - 08/2007
2Anti-Bacterial Agents (Antibiotics)IBA
12/2014 - 10/2009
2Interferon-gamma (Interferon, gamma)IBA
07/2014 - 08/2013
2Interleukin-10 (Interleukin 10)IBA
07/2014 - 08/2013
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 07/2003
2CarcinogensIBA
01/2014 - 12/2007
2Small Interfering RNA (siRNA)IBA
08/2013 - 11/2011
2Coloring Agents (Dyes)IBA
04/2013 - 06/2007
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2013 - 09/2010
2Cyclin D1IBA
03/2012 - 01/2011
2Phosphotransferases (Kinase)IBA
02/2012 - 11/2011
2PhytochemicalsIBA
02/2012 - 10/2010
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2011 - 09/2010
2AminoglycosidesIBA
07/2011 - 01/2008
2ErbB Receptors (EGF Receptor)IBA
04/2011 - 03/2009
2(1- (4- chloro- 3- nitrobenzenesulfonyl)- 1H- indol- 3- yl)- methanolIBA
10/2010 - 08/2007
2Tumor Biomarkers (Tumor Markers)IBA
07/2010 - 11/2002
2Crystallins (Crystallin)IBA
01/2010 - 02/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2005 - 01/2002
2Thallium-201IBA
07/2003 - 03/2003
1Indicators and Reagents (Reagents)IBA
03/2022
1AntioxidantsIBA
04/2021
1EnzymesIBA
04/2021
1Acetylcysteine (Siran)FDA LinkGeneric
04/2021
1Metformin (Glucophage)FDA LinkGeneric
02/2021
1PlatinumIBA
01/2021
1Cetuximab (Erbitux)FDA Link
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Angiotensin Receptor AntagonistsIBA
10/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2020
1calyculin AIBA
07/2020
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
07/2020

Therapy/Procedure

13Therapeutics
02/2022 - 08/2007
6Radiotherapy
11/2010 - 11/2002
3Aftercare (After-Treatment)
03/2017 - 09/2010
2Free Tissue Flaps
02/2022 - 10/2018
2Laryngoplasty
10/2021 - 01/2016
2Length of Stay
07/2021 - 12/2014
2Chemoradiotherapy
03/2015 - 06/2009
2Tracheostomy
10/2009 - 01/2008
1Sutures (Suture)
07/2021